Parents—do you have questions left unanswered? Healthcare Professionals—do you want to know what’s most useful to your clinic patients? Access CF caregivers and healthcare professionals and get your questions answered here!
Cystic Fybrosis Learning Center
Online Courses
On-Demand Webcast:
Effectively Managing Pseudomonas aeruginosa with Early Eradication and Chronic Suppressive Therapy in CF: Focus on Treatment Timeline, Biofilms, Pharmacodynamic Properties, and Drug Delivery
(CME, CNE, CPE, CPE for Dietitians)
News
05/08/2012
New Combination Therapy Improves Breathing Function in CF Patients
Interim results of phase II trials for a combination therapy of approved CF drug Kalydeco and experimental VX-809 showed an improvement in lung function by 5 percent in 46 percent of patients and 10% improvement in 30% of patients.
Read More04/30/2012
Medical Product Developer Gains European Marketing Approval for CF Therapy
The European Commission has granted marketing approval for Bronchitol, new therapy used to clear CF airways.
Read More04/24/2012
Gene Responsible for Newborn CF Patient Intestinal Obstruction Identified
Johns Hopkins researchers have identified the gene that influences the risk involved with developing neonatal intestinal obstruction in newborns that have cystic fibrosis.
Read More CFLC Ad
